[1]
Ahmadian Davoudi, S. et al. 2026. Development and Experimental Evaluation of a Multi-Epitope Nanolipopeptide Platform Targeting PD-1, PD-L1, and HER2 for Gastric Adenocarcinoma Immunotherapy. Archives of Advances in Biosciences. 17, 1 (Sep. 2026), 1–15. DOI:https://doi.org/10.22037/aab.v17i1.52476.